Stanley Friedman

Array ( [id] => 2951561 [patent_doc_number] => 05221687 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-22 [patent_title] => 'Medicaments' [patent_app_type] => 1 [patent_app_number] => 7/934307 [patent_app_country] => US [patent_app_date] => 1992-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3666 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/221/05221687.pdf [firstpage_image] =>[orig_patent_app_number] => 934307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2976539 [patent_doc_number] => 05256669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-26 [patent_title] => 'Methods and compositions for treating acute or chronic pain and drug addiction' [patent_app_type] => 1 [patent_app_number] => 7/926719 [patent_app_country] => US [patent_app_date] => 1992-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5573 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/256/05256669.pdf [firstpage_image] =>[orig_patent_app_number] => 926719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2937404 [patent_doc_number] => 05260337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-09 [patent_title] => 'Ibuprofen-muscle relaxant combinations' [patent_app_type] => 1 [patent_app_number] => 7/921882 [patent_app_country] => US [patent_app_date] => 1992-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1687 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/260/05260337.pdf [firstpage_image] =>[orig_patent_app_number] => 921882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2978068 [patent_doc_number] => 05252600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-12 [patent_title] => 'Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 7/919279 [patent_app_country] => US [patent_app_date] => 1992-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6066 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/252/05252600.pdf [firstpage_image] =>[orig_patent_app_number] => 919279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2962666 [patent_doc_number] => 05264459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-23 [patent_title] => 'Use of .beta.-adrenergic agonists to treat patients with demyelinating or autoimmune diseases' [patent_app_type] => 1 [patent_app_number] => 7/913673 [patent_app_country] => US [patent_app_date] => 1992-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11856 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/264/05264459.pdf [firstpage_image] =>[orig_patent_app_number] => 913673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3009158 [patent_doc_number] => 05276059 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-04 [patent_title] => 'Inhibition of diseases associated with amyloid formation' [patent_app_type] => 1 [patent_app_number] => 7/912097 [patent_app_country] => US [patent_app_date] => 1992-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7006 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/276/05276059.pdf [firstpage_image] =>[orig_patent_app_number] => 912097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2934631 [patent_doc_number] => 05229407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-20 [patent_title] => 'Medicaments' [patent_app_type] => 1 [patent_app_number] => 7/911395 [patent_app_country] => US [patent_app_date] => 1992-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4095 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/229/05229407.pdf [firstpage_image] =>[orig_patent_app_number] => 911395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3050900 [patent_doc_number] => 05283257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-01 [patent_title] => 'Method of treating hyperproliferative vascular disease' [patent_app_type] => 1 [patent_app_number] => 7/911681 [patent_app_country] => US [patent_app_date] => 1992-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5655 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/283/05283257.pdf [firstpage_image] =>[orig_patent_app_number] => 911681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2904477 [patent_doc_number] => 05248690 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-28 [patent_title] => 'Method for treatment of neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 7/909881 [patent_app_country] => US [patent_app_date] => 1992-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3057 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/248/05248690.pdf [firstpage_image] =>[orig_patent_app_number] => 909881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2953628 [patent_doc_number] => 05242916 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-07 [patent_title] => 'Method for treatment of neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 7/909906 [patent_app_country] => US [patent_app_date] => 1992-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2878 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/242/05242916.pdf [firstpage_image] =>[orig_patent_app_number] => 909906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3008988 [patent_doc_number] => 05276050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-04 [patent_title] => 'Medicaments' [patent_app_type] => 1 [patent_app_number] => 7/908329 [patent_app_country] => US [patent_app_date] => 1992-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3002 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 318 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/276/05276050.pdf [firstpage_image] =>[orig_patent_app_number] => 908329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2932916 [patent_doc_number] => 05196421 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-23 [patent_title] => 'Excitatory amino acid receptor antagonists in methods for the use thereof' [patent_app_type] => 1 [patent_app_number] => 7/904358 [patent_app_country] => US [patent_app_date] => 1992-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9978 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/196/05196421.pdf [firstpage_image] =>[orig_patent_app_number] => 904358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2894160 [patent_doc_number] => 05240917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-31 [patent_title] => 'Suppression of thromboxane levels by percutaneous administration of aspirin' [patent_app_type] => 1 [patent_app_number] => 7/899209 [patent_app_country] => US [patent_app_date] => 1992-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5466 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/240/05240917.pdf [firstpage_image] =>[orig_patent_app_number] => 899209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2936459 [patent_doc_number] => 05260289 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-09 [patent_title] => 'Composition for treating pain, method for treating pain and composition for reinforcing pain relief action' [patent_app_type] => 1 [patent_app_number] => 7/898032 [patent_app_country] => US [patent_app_date] => 1992-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2744 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/260/05260289.pdf [firstpage_image] =>[orig_patent_app_number] => 898032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2895463 [patent_doc_number] => 05244897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-14 [patent_title] => 'Glycyl-p-amino-pyridine for the treatment of senile dementia states' [patent_app_type] => 1 [patent_app_number] => 7/853780 [patent_app_country] => US [patent_app_date] => 1992-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2090 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/244/05244897.pdf [firstpage_image] =>[orig_patent_app_number] => 853780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3085941 [patent_doc_number] => 05284861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-08 [patent_title] => 'Pharmaceutical composition comprising flupirtine and its use to combat Parkinson disorders' [patent_app_type] => 1 [patent_app_number] => 7/890730 [patent_app_country] => US [patent_app_date] => 1992-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4041 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/284/05284861.pdf [firstpage_image] =>[orig_patent_app_number] => 890730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2890333 [patent_doc_number] => 05210088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-11 [patent_title] => 'Method of treatment and heterocyclic compounds used therein' [patent_app_type] => 1 [patent_app_number] => 7/888665 [patent_app_country] => US [patent_app_date] => 1992-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8747 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/210/05210088.pdf [firstpage_image] =>[orig_patent_app_number] => 888665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2930733 [patent_doc_number] => 05232932 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-03 [patent_title] => 'Method for treatment of neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 7/887192 [patent_app_country] => US [patent_app_date] => 1992-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2961 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/232/05232932.pdf [firstpage_image] =>[orig_patent_app_number] => 887192 [rel_patent_id] =>[rel_patent_doc_number] =>)